PRPOPrecipio, Inc.

Nasdaq precipiodx.com


$ 6.30 $ -0.25 (-3.85 %)    

Wednesday, 15-May-2024 15:16:26 EDT
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 6.2401
$ 6.26
$ 0.00 x 0
$ 0.00 x 0
$ 6.26 - $ 6.30
$ 4.75 - $ 14.80
1,658
na
8.9M
$ 1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-29-2021 12-31-2020 10-K
15 11-13-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-27-2020 12-31-2019 10-K
19 11-13-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-16-2019 03-31-2019 10-Q
22 04-16-2019 12-31-2018 10-K
23 11-19-2018 09-30-2018 10-Q
24 08-16-2018 06-30-2018 10-Q
25 05-21-2018 03-31-2018 10-Q
26 04-13-2018 12-31-2017 10-K
27 11-20-2017 09-30-2017 10-Q
28 08-22-2017 06-30-2017 10-Q
29 05-18-2017 03-31-2017 10-Q
30 04-13-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-15-2016 06-30-2016 10-Q
33 05-23-2016 03-31-2016 10-Q
34 04-14-2016 12-31-2015 10-K
35 11-16-2015 09-30-2015 10-Q
36 08-14-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 04-15-2015 12-31-2014 10-K
39 11-12-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces it has entered into a distribution agreement with C...

 precipios-q4-2023-cash-burn-from-operations-drops-below-100k-for-the-full-quarter-precipios-end-of-quarter-cash-balance-changed-from-15m-at-the-end-of-q3-2024-to-14m-as-of-dec-31-2023

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces that continued revenue growth generated cash levels...

 precipio-signs-distribution-agreement-for-iv-cell-and-hemescreen-in-japan

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces it has entered into an agreement with a Japanese di...

 precipio-sees-q3-revenue-45m-vs-4m-est

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that Q3-2023 (unaudited) revenues have increased 2...

 precipio-inc-has-regained-compliance-with-nasdaq-bid-price-rule

- SEC Filing

 precipio-continues-to-sign-new-hemescreen-customers-expected-to-bring-total-q4-hemescreen-revenues-to-an-estimated-12m

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announced that new customer orders are expected to bring tota...

 precipio-reduces-product-revenue-result-needed-for-cash-flow-breakeven-from-8m-to-6m-annually-or-15m-per-quarter-25-below-previous-estimates

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announced that due to the increased pathology revenue, and th...

 stocks-that-hit-52-week-lows-on-thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-monday

  Monday's session saw 175 companies set new 52-week lows.

 precipios-earnings-a-preview
Precipio's Earnings: A Preview
08/16/2023 16:01:00

 precipio-launches-quantitative-bcr-abl-20-panel

The following features make this product the most advanced BCR-ABL panel on the market, besting competition in terms of robust ...

 precipios-operational-efficiency-measures-continue-to-reduce-cash-burn-and-move-the-company-towards-breakeven-precipio-is-projected-to-report-cash-burn-of-31m

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces significant reductions in its cash-burn. For the s...

 precipio-inc-announces-that-q2-revenues-have-increased-to-35m-from-28m-in-q1-2023-an-increase-of-25-qoq

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that Q2-2023 revenues have increased to $3.5M in Q...

 stocks-that-hit-52-week-lows-on-friday

  Friday's session saw 59 companies set new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION